{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:17:26Z","timestamp":1760660246623,"version":"build-2065373602"},"reference-count":24,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2015,5,18]],"date-time":"2015-05-18T00:00:00Z","timestamp":1431907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","resmedjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Medicine"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/j.rmed.2015.05.012","type":"journal-article","created":{"date-parts":[[2015,5,22]],"date-time":"2015-05-22T16:14:30Z","timestamp":1432311270000},"page":"1031-1039","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Indacaterol vs tiotropium in COPD patients classified as GOLD A and B"],"prefix":"10.1016","volume":"109","author":[{"given":"Donald A.","family":"Mahler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huib A.M.","family":"Kerstjens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Donohue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland","family":"Buhl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pablo","family":"Altman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2015","series-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease","author":"Global initiative for chronic Obstructive Lung Disease (GOLD)","key":"10.1016\/j.rmed.2015.05.012_bib1"},{"key":"10.1016\/j.rmed.2015.05.012_bib2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-2600(13)70158-9","article-title":"Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): a randomised, blinded, parallel-group study","volume":"1","author":"Decramer","year":"2013","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmed.2015.05.012_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1183\/09031936.00127809","article-title":"Tiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trial","volume":"36","author":"Troosters","year":"2010","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2015.05.012_bib4","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.rmed.2012.08.022","article-title":"Indacaterol therapy in patients with COPD not receiving other maintenance treatment","volume":"106","author":"Decramer","year":"2012","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2015.05.012_bib5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1164\/rccm.200910-1500OC","article-title":"Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium","volume":"182","author":"Donohue","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2015.05.012_bib6","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1183\/09031936.00191810","article-title":"Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD","volume":"38","author":"Buhl","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2015.05.012_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1081\/COPD-200053377","article-title":"Minimal clinically important differences in COPD lung function","volume":"2","author":"Donohue","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2015.05.012_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1378\/chest.93.3.580","article-title":"Evaluation of clinical methods for rating dyspnea","volume":"93","author":"Mahler","year":"1988","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2015.05.012_bib9","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1378\/chest.85.6.751","article-title":"The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes","volume":"85","author":"Mahler","year":"1984","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2015.05.012_bib10","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1081\/COPD-200050666","article-title":"The MCID of the transition dyspnea index is a total score of one unit","volume":"2","author":"Mahler","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2015.05.012_bib11","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1081\/COPD-200050513","article-title":"St. George's Respiratory Questionnaire: MCID","volume":"2","author":"Jones","year":"2005","journal-title":"COPD"},{"key":"10.1016\/j.rmed.2015.05.012_bib12","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1164\/rccm.201310-1863PP","article-title":"Minimal clinically important differences in pharmacological trials","volume":"189","author":"Jones","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"year":"2007","series-title":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease","author":"Global Initiative for chronic Obstructive Lung Disease (GOLD)","key":"10.1016\/j.rmed.2015.05.012_bib13"},{"key":"10.1016\/j.rmed.2015.05.012_bib14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(09)61298-8","article-title":"Effect of tiotropium on outcomes in patients with moderate chronic obstructive pulmonary disease (UPLIFT): a prespecified subgroup analysis of a randomised controlled trial","volume":"374","author":"Decramer","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.rmed.2015.05.012_bib15","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.rmed.2008.11.019","article-title":"An economic analysis of pharmacological treatment of COPD in Spain","volume":"103","author":"Miravitlles","year":"2009","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2015.05.012_bib16","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.rmed.2014.03.002","article-title":"Understanding the GOLD 2011 strategy as applied to a real-world COPD population","volume":"105","author":"Vestbo","year":"2014","journal-title":"Respir Med"},{"key":"10.1016\/j.rmed.2015.05.012_bib17","doi-asserted-by":"crossref","first-page":"92","DOI":"10.4104\/pcrj.2012.00092","article-title":"Risk-to-benefit ratio of inhaled corticosteroids in patients with COPD","volume":"22","author":"Price","year":"2013","journal-title":"Prim Care Respir J"},{"key":"10.1016\/j.rmed.2015.05.012_bib18","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1183\/09031936.00195212","article-title":"Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort","volume":"42","author":"Agusti","year":"2013","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2015.05.012_bib19","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1378\/chest.07-0703","article-title":"Validity and responsiveness of the self-administered computerized versions of the baseline and transition dyspnea indexes","volume":"132","author":"Mahler","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.rmed.2015.05.012_bib20","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1164\/ajrccm.158.4.9802091","article-title":"Analysis of clinical methods used to evaluate dyspnea in patients with chronic obstructive pulmonary disease","volume":"158","author":"Hajiro","year":"1998","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.rmed.2015.05.012_bib21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1183\/09031936.00177210","article-title":"Properties of the COPD assessment test in a cross-sectional European study","volume":"38","author":"Jones","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/j.rmed.2015.05.012_bib22","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1186\/1465-9921-11-135","article-title":"Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium","volume":"11","author":"Vogelmeier","year":"2010","journal-title":"Respir Res"},{"key":"10.1016\/j.rmed.2015.05.012_bib23","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(14)70008-6","article-title":"Opportunities to diagnose chronic obstructive pulmonary disease in routine care in the UK: a retrospective study of a clinical cohort","volume":"2","author":"Jones","year":"2014","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.rmed.2015.05.012_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.pupt.2015.02.008","article-title":"The impact of treatment with indacaterol in patients with COPD: a post-hoc analysis according to GOLD 2011 categories A to D","author":"Kerstjens","year":"2015","journal-title":"Pulm Pharmacol Ther"}],"container-title":["Respiratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611115001821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0954611115001821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T11:32:18Z","timestamp":1760614338000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0954611115001821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8]]},"references-count":24,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S0954611115001821"],"URL":"https:\/\/doi.org\/10.1016\/j.rmed.2015.05.012","relation":{},"ISSN":["0954-6111"],"issn-type":[{"type":"print","value":"0954-6111"}],"subject":[],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indacaterol vs tiotropium in COPD patients classified as GOLD A and B","name":"articletitle","label":"Article Title"},{"value":"Respiratory Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.rmed.2015.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}